GoldenGolden
Advanced Search
Orig3n

Orig3n

Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.

Orig3n is a biotechnology company headquartered in Boston, Massachusetts developing personalized regenerative medicine treatments based on patient genetic profiles that was founded on April 10, 2014 by Kate Blanchard and Robin Smith.

Orig3n specialized in developing personalized regenerative medicine treatments for rare and genetically inherited diseases. They offer medical practitioners and scientific researchers a bio-repository of induced pluripotent stem cells for developing new medical treatments called LifeCapsule, and a platform for creating cellular models using the LifeCapsule bio-repository called LifeSystems.

Funding
Venture round

On February 15, 2015 Orig3n completed a venture capital funding round with $3.1 million in funding from Mountain Group Capital, KTB Ventures, Hatteras Venture Partners, and 180 Degrees Capital.

Series A

On December 12, 2015 Orig3n completed their series A funding round with $12.5 million in funding from Syno Capital (lead investor), Hatteras Venture Partners, (lead investor), Mountain Group Capital, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.

Venture round

On June 27, 2017 Orig3n completed another venture capital round with $20 million in funding from Hatteras Venture Partners (lead investor), Syno Capital, Spectrum Health Ventures, MGC Venture Partners, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.

Series B

On June 12, 2018 Orig3n completed their series B funding round with an undisclosed amount of funding (of at least $14.4 million) from Haitong International Securities Group (lead investor), Vectr Ventures, Spectrum Health Ventures, Mountain Group Capital, MMIC Investment Holdings, LabCorp, KTB Ventures, Hatteras Venture Partners, Defta Partners, Alexandria Venture Investments, and 180 Degree Capital.

Partnerships
U.S. Ski & Snowboard Team

On January 15, 2019 Orig3n became the Official Genetics Partner of the U.S. Ski & Snowboard Team. Orig3n will be helping members of the Ski & Snowboard team in Park City, Utah develop specialized health programs for improving their training, performance, and recovery.

Timeline

September 2020
Orig3n raises a $26,200,000 venture round.
January 15, 2019
Partnership: U.S. Ski & Snowboard Team

On January 15, 2019 Orig3n became the Official Genetics Partner of the U.S. Ski & Snowboard Team. Orig3n will be helping members of the Ski & Snowboard team in Park City, Utah develop specialized health programs for improving their training, performance, and recovery.

July 2018
Orig3n raises a $50,000,000 series B round from DEFTA Partners, Haitong International Securities Group Limited, Hatteras Venture Partners, KTB Ventures, LabCorp, MMIC Investment Holdings, Mountain Group Capital, Spectrum Health Ventures and VECTR Ventures.
June 12, 2018
Series B funding round

On June 12, 2018 Orig3n completed their series B funding round with an undisclosed amount of funding (of at least $14.4 million) from Haitong International Securities Group (lead investor), Vectr Ventures, Spectrum Health Ventures, Mountain Group Capital, MMIC Investment Holdings, LabCorp, KTB Ventures, Hatteras Venture Partners, Defta Partners, Alexandria Venture Investments, and 180 Degree Capital.

June 27, 2017
Venture funding round

On June 27, 2017 Orig3n completed another venture capital round with $20 million in funding from Hatteras Venture Partners (lead investor), Syno Capital, Spectrum Health Ventures, MGC Venture Partners, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.

June 2017
Orig3n raises a $20,000,000 venture round from 180 Degree Capital Corp, DEFTA Partners, Hatteras Venture Partners, LabCorp, MGC Venture Partners, Spectrum Health Ventures and Syno Capital.
December 12, 2015
Series A funding round

On December 12, 2015 Orig3n completed their series A funding round with $12.5 million in funding from Syno Capital (lead investor), Hatteras Venture Partners, (lead investor), Mountain Group Capital, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.

December 2015
Orig3n raises a $12,500,000 series A round from 180 Degree Capital Corp, DEFTA Partners, Hatteras Venture Partners, LabCorp, Mountain Group Capital and Syno Capital.
February 15, 2015
Venture round funding round

On February 15, 2015 Orig3n completed a venture capital funding round with $3.1 million in funding from Mountain Group Capital, KTB Ventures, Hatteras Venture Partners, and 180 Degrees Capital.

February 2015
Orig3n raises a $3,100,000 venture round from 180 Degree Capital Corp, Hatteras Venture Partners, KTB Ventures and Mountain Group Capital.
Page 1 of 2

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

U.S. Ski & Snowboard and Orig3n in Multi-Year Partnership

Orig3n Inc.

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.